FSSNX | MSCDX | FSSNX / MSCDX | |
Total Expense Ratio | 0.03 | 0.75 | 3% |
Annual Report Gross Expense Ratio | 0.03 | 0.76 | 3% |
Fund Existence | 14 years | 21 years | - |
Gain YTD | 3.468 | 4.252 | 82% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 25.9B | 482M | 5,373% |
Annual Yield % from dividends | 0.90 | 0.58 | 156% |
Returns for 1 year | 8.73 | 0.82 | 1,059% |
Returns for 3 years | 18.75 | 11.44 | 164% |
Returns for 5 years | 51.48 | 28.78 | 179% |
Returns for 10 years | 85.72 | 24.23 | 354% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 138.76 | 1.49 | +1.09% |
iShares Biotechnology ETF | |||
AVSE | 60.51 | 0.04 | +0.07% |
Avantis Responsible Emerging Mkts Eq ETF | |||
FLCV | 29.80 | -0.06 | -0.19% |
Federated Hermes MDT Large Cap Value ETF | |||
SSUS | 46.37 | -0.12 | -0.27% |
Day Hagan Smart Sector ETF | |||
UMDD | 23.81 | -0.45 | -1.87% |
ProShares UltraPro MidCap400 |